Literature DB >> 17359937

The vinyl-sulfonium bond in human myeloperoxidase: impact on compound I formation and reduction by halides and thiocyanate.

Martina Zederbauer1, Paul Georg Furtmüller, Bernadette Ganster, Nicole Moguilevsky, Christian Obinger.   

Abstract

In human myeloperoxidase (MPO) the heme is covalently attached to the protein via two ester linkages and a unique sulfonium ion linkage between the sulfur atom of Met243 and the beta-carbon of the vinyl ring on pyrrole ring A. Here, we have investigated the variant Met243Val produced in Chinese hamster ovary cells in order to elucidate the role of the electron withdrawing sulfonium bond in compound I formation and reduction. Disruption of this MPO-typical bond causes a blue-shifted UV-vis spectrum and an increase in the heme flexibility. This had no impact on compound I formation mediated by hydrogen peroxide (2.2x10(7) M(-1)s(-1) at pH 7.0 and 25 degrees C). Compared with wild-type recombinant MPO the cyanide association rate with ferric Met243Val was significantly enhanced as were also the calculated apparent bimolecular compound I reduction rates by iodide (>10(8) M(-1)s(-1)) and thiocyanate (>10(8) M(-1)s(-1)). By contrast, the overall chlorination and bromination activities were decreased by 98.1% and 87.4%, respectively, compared with the wild-type protein. Compound I reduction by chloride was slower than compound I decay to a compound II-like species (0.4 s(-1)), whereas compound I reduction by bromide was about 10-times slower (1.3x10(4) M(-1)s(-1)) than the wild-type rate. These findings are discussed with respect to the known crystal structure of MPO and its bromide complex as well as the known redox chemistry of its intermediates and substrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359937     DOI: 10.1016/j.bbrc.2007.02.157

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Inhibition of Myeloperoxidase.

Authors:  Jala Soubhye; Paul G Furtmüller; Francois Dufrasne; Christian Obinger
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

3.  Myeloperoxidase scavenges peroxynitrite: A novel anti-inflammatory action of the heme enzyme.

Authors:  Chintan N Koyani; Joerg Flemmig; Ernst Malle; Juergen Arnhold
Journal:  Arch Biochem Biophys       Date:  2015-02-27       Impact factor: 4.013

4.  Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation.

Authors:  Irina Grishkovskaya; Martina Paumann-Page; Rupert Tscheliessnig; Johanna Stampler; Stefan Hofbauer; Monika Soudi; Benjamin Sevcnikar; Chris Oostenbrink; Paul G Furtmüller; Kristina Djinović-Carugo; William M Nauseef; Christian Obinger
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

5.  Insights into the Active Site of Coproheme Decarboxylase from Listeria monocytogenes.

Authors:  Lisa Milazzo; Stefan Hofbauer; Barry D Howes; Thomas Gabler; Paul G Furtmüller; Christian Obinger; Giulietta Smulevich
Journal:  Biochemistry       Date:  2018-03-22       Impact factor: 3.162

6.  Pre-steady-state Kinetics Reveal the Substrate Specificity and Mechanism of Halide Oxidation of Truncated Human Peroxidasin 1.

Authors:  Martina Paumann-Page; Romy-Sophie Katz; Marzia Bellei; Irene Schwartz; Eva Edenhofer; Benjamin Sevcnikar; Monika Soudi; Stefan Hofbauer; Gianantonio Battistuzzi; Paul G Furtmüller; Christian Obinger
Journal:  J Biol Chem       Date:  2017-01-31       Impact factor: 5.157

7.  How covalent heme to protein bonds influence the formation and reactivity of redox intermediates of a bacterial peroxidase.

Authors:  Markus Auer; Andrea Nicolussi; Georg Schütz; Paul G Furtmüller; Christian Obinger
Journal:  J Biol Chem       Date:  2014-09-22       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.